Achieving Firsts In Biosimilars From China

Explore this insightful article and exclusive video with Henlius’ COO to discover:

  • Its achievements in biosimilar approvals, including serplulimab, and its anticipated launch into the European market.
  • The essential role of strategic partnerships in Henlius’ success, including over 20 global collaborations with Abbott Laboratories, Accord Healthcare, Eurofarma and more.
  • An overview of Henlius’ late-stage pipeline drugs, and ambitious plans shaping the future of biosimilars.

Click here to download this Special Report in PDF format



More from Partnered Content

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

In Partnership With

Achieving Firsts In Biosimilars From China

Discover Henlius’ groundbreaking achievements, and their mission to deliver affordable, innovative drugs worldwide through strategic partnerships.

More from Products

In partnership with

Podcast: Navigating the Future of Hepatology Clinical Trials

Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics.

In partnership with

Podcast Series: Navigating Regulatory Changes & Market Dynamics: CRO Perspectives on the Future of Clinical Trials

Insights from Novotech on Evolving Trends Impacting Global Clinical Development

Sponsored by:

Making medicines more affordable to the NHS

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Sponsored by:

Japan’s Strengths As A Clinical Study Location And Why Selecting The Right Partner Is Crucial

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.